SHIFT Newsroom · GLOBAL
Adolescent obesity: review highlights long-term evidence gaps
This review examines incretin-based treatments during adolescence. It summarises existing research rather than reporting a new trial. Adolescent eligibility, licensed indications and specialist care differ from an adult weight-management service.
What the source says
This review examines incretin-based treatments during adolescence. It summarises existing research rather than reporting a new trial. Adolescent eligibility, licensed indications and specialist care differ from an adult weight-management service.
Evidence and limits
The review discusses existing efficacy evidence and short-term adverse effects, while identifying gaps around growth, puberty and longer-term development. An adult service cannot simply transfer its treatment criteria to adolescents.
What we checked
We checked the primary publication record and available abstract. The full paper and supplements have not been reviewed for this correction.
SHIFT’s take
This is specialist adolescent research. My Timber’s adult support and adult treatment information are a separate scope.
Known facts
- This review examines incretin-based treatments during adolescence.